Liothyronine prescribing in England: costs versus need.
作者信息
Heald Adrian, Stedman Mike, Okosieme Buchi, Premawardhana Lakdasa, Taylor Peter, Dayan Colin
机构信息
The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester M14 4PX, UK; Department of Diabetes and Endocrinology, Salford Royal NHS Foundation Trust, Salford, UK.
RES Consortium, Andover, UK.
出版信息
Lancet. 2023 Dec 2;402(10417):2074-2075. doi: 10.1016/S0140-6736(23)01792-0. Epub 2023 Nov 15.
Abstract
摘要
相似文献
1
Liothyronine prescribing in England: costs versus need.英格兰的三碘甲状腺原氨酸处方：成本与需求
Lancet. 2023 Dec 2;402(10417):2074-2075. doi: 10.1016/S0140-6736(23)01792-0. Epub 2023 Nov 15.
2
Liothyronine (LT3) prescribing in England: Are cost constraints inhibiting guideline implementation?左甲状腺素（LT3）在英格兰的处方情况：成本限制是否阻碍了指南的实施？
Clin Endocrinol (Oxf). 2024 Jul;101(1):62-68. doi: 10.1111/cen.15061. Epub 2024 May 16.
3
Trends in costs and prescribing for liothyronine and levothyroxine in England and wales 2011-2020.2011-2020 年英格兰和威尔士左甲状腺素和甲状腺素的费用和处方趋势。
Clin Endocrinol (Oxf). 2021 Jun;94(6):980-989. doi: 10.1111/cen.14414. Epub 2021 Mar 21.
4
Liothyronine and levothyroxine prescribing in England: A comprehensive survey and evaluation.在英国，左甲状腺素和甲状腺素的处方情况：一项全面的调查和评估。
Int J Clin Pract. 2021 Sep;75(9):e14228. doi: 10.1111/ijcp.14228. Epub 2021 Jul 6.
5
Trends and variation in prescribing of low-priority treatments identified by NHS England: a cross-sectional study and interactive data tool in English primary care.英格兰国民保健制度确定的低优先级治疗方案的开具趋势和变化：英国初级医疗保健中的一项横断面研究和交互式数据工具。
J R Soc Med. 2018 Jun;111(6):203-213. doi: 10.1177/0141076818769408. Epub 2018 May 22.
6
Liothyronine cost and prescriptions in England.英格兰的三碘甲状腺原氨酸成本与处方情况。
Lancet Diabetes Endocrinol. 2019 Jan;7(1):11-12. doi: 10.1016/S2213-8587(18)30334-6.
7
Explaining variations in prescribing costs across England.解释英格兰各地处方费用的差异。
BMJ. 1993 Jun 26;306(6894):1731-4. doi: 10.1136/bmj.306.6894.1731.
8
Explaining variations in general practice prescribing costs per ASTRO-PU (age, sex, and temporary resident originated prescribing unit).解释每个ASTRO-PU（年龄、性别和临时居民来源的处方单位）在全科医疗处方成本上的差异。
BMJ. 1996 Feb 24;312(7029):488-9. doi: 10.1136/bmj.312.7029.488.
9
What can PACT tell us about prescribing in general practice?PACT能告诉我们关于全科医疗中的处方情况有哪些信息？
BMJ. 1997 Dec 6;315(7121):1515-9. doi: 10.1136/bmj.315.7121.1515.
10
Comparison of prescribing unit with index including both age and sex in assessing general practice prescribing costs.在评估全科医疗处方成本时，将处方单位与涵盖年龄和性别的指数进行比较。
BMJ. 1993 Feb 20;306(6876):496-8. doi: 10.1136/bmj.306.6876.496.
引用本文的文献
1
How Does Thyroid Hormone Profile Differ on and Off Replacement Treatment?甲状腺激素水平在替代治疗期间及停药后有何差异？
Clin Endocrinol (Oxf). 2025 Apr;102(4):490-495. doi: 10.1111/cen.15185. Epub 2024 Dec 19.
Zotero 插件